The Patent Finder

Imbria Pharmaceuticals, Inc.

23 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 22, 2027
    The maintenance fee for Methods of treating non-obstructive hypertrophic cardiomyopathy using modified forms of trimetazidine (US 11,730,733) comes due Feb 22, 2027. Unpaid by Aug 23, 2027, it lapses early.
  • 1 fee due Mar 5, 2027
    The maintenance fee for Crystal Forms of 2-[4-[(2,3,4-Trimethoxyphenyl)METHYL]PIPERAZIN-1-YL]ETHYL PYRIDINE-3-Carboxylate (US 11,746,090) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
  • 2 fees due Apr 10 to 24, 2027 · next Apr 10
  • 1 fee due Jun 19, 2027
    The maintenance fee for Compositions and Methods for Increasing Efficiency of Cardiac Metabolism (US 11,844,840) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
  • 1 fee due Jul 30, 2027
    The maintenance fee for Methods of treating kidney conditions using modified forms of trimetazidine (US 11,883,396) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
  • 1 fee due Aug 11, 2027
    The maintenance fee for Compositions and Methods for Increasing Efficiency of Cardiac Metabolism (US 10,556,013) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Methods of treating heart failure with reduced ejection fraction using modified forms of trimetazidine (US 11,969,422) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,786,476Combination therapy
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,556,013Compositions and Methods for Increasing Efficiency of Cardiac Metabolism
In force
 · High confidence
In forceHigh confidence
US 10,918,728Compositions and Methods for Increasing Efficiency of Cardiac Metabolism
In force
 · Low confidence
In forceLow confidence
US 10,953,102Compositions and Methods for Increasing Efficiency of Cardiac Metabolism
In force
 · Low confidence
In forceLow confidence
US 11,376,330Compositions and Methods for Increasing Efficiency of Cardiac Metabolism
In force
 · Low confidence
In forceLow confidence
US 11,844,840Compositions and Methods for Increasing Efficiency of Cardiac Metabolism
In force
 · Low confidence
In forceLow confidence
US 12,318,453Compositions and Methods for Increasing Efficiency of Cardiac Metabolism
In force
 · Low confidence
In forceLow confidence
US 11,530,184Crystal Forms of 2-[4-[(2,3,4-Trimethoxyphenyl)METHYL]PIPERAZIN-1-YL]ETHYL PYRIDINE-3-Carboxylate
In force
 · High confidence
In forceHigh confidence
US 11,746,090Crystal Forms of 2-[4-[(2,3,4-Trimethoxyphenyl)METHYL]PIPERAZIN-1-YL]ETHYL PYRIDINE-3-Carboxylate
In force
 · High confidence
In forceHigh confidence
US 12,065,410Crystal Forms of 2-[4-[(2,3,4-Trimethoxyphenyl)METHYL]PIPERAZIN-1-YL]ETHYL PYRIDINE-3-Carboxylate
In force
 · High confidence
In forceHigh confidence
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

12 pending · 1 abandoned · 9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited